← Back to Search

Aromatherapy for Breast and Prostate Cancer

N/A

Waitlist Available

Led By Amy M Ross, Ph.D.

Research Sponsored by OHSU Knight Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Criteria for solid tumors: Participants must have measurable disease, per MD and data in medical record

Participants must have histologically or cytologically confirmed hormone receptor positive (HR+) HER2 negative (-) breast cancer or prostate cancer (hormone therapy excepted) who are in Stage I-III with or without evidence of metastasis using the Cancer Therapy Evaluation Program (CTEP) Simplified Disease Classification

Must not have

Had surgery or invasive procedure in the past two months. Rationale, because of their poor prognosis rather than being in early stages of cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and at day 3 or 4 and on day 7

Awards & highlights

No Placebo-Only Group

Summary

This trial uses virtual reality and smells to study if it can improve the immune system for cancer patients who have completed chemo or radiation therapy.

Who is the study for?

This trial is for adults over 18 who were diagnosed with stage I-III hormone receptor positive, HER2 negative breast or prostate cancer within the last year. They must understand and consent to the study, have measurable disease, and no history of autoimmune diseases. Smokers or those with recent infections, surgeries, asthma, allergies to citrus peel or pine forests are excluded.

What is being tested?

The study tests if aromatherapy using humidified forest oils can boost immune cells in patients who've completed chemo/radiation therapy for early-stage breast or prostate cancer. It aims to simulate forest therapy indoors for those unable to engage in outdoor activities.

What are the potential side effects?

Potential side effects may include contact dermatitis (skin irritation) and coughing due to reactions from the forest oils used during aromatherapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My solid tumor can be measured by my doctor.

Select...

My breast or prostate cancer is hormone receptor positive and HER2 negative, at Stage I-III.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I had surgery or an invasive procedure within the last two months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and at day 3 or 4 and on day 7

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and at day 3 or 4 and on day 7

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at day 3 or 4 and on day 7 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Humidified phytoncides to simulate the forest greenspace immersion (SFIT)

Secondary study objectives

Collecting and analyzing immune system measures while deploying the simulated forest immersion therapy with forest oils

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (SFIT, biospecimen, interview)Experimental Treatment1 Intervention

Patients participate in SFIT, using humidified wood and fragrance oils, over 1 hour. on day 1, day 3 or 4 and on day 7. Patients also undergo blood sample collection at baseline and on days 3 or 4 and 7 and participate in interviews at baseline and post-treatment.

0 / 3Eligibility criteria met